Stay updated on Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A general NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:46:16.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision marker changed from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T19:47:23.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study record content, removing access to the NCT04345367 trial details and locations. This replaces the prior study information with an error page, affecting how users can view or reference this trial on ClinicalTrials.gov.
    Difference
    18%
    Check dated 2026-09-22T21:49:50.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.6 to v3.7.0, indicating a minor update to the page system or content without changing the study information.
    Difference
    0.0%
    Check dated 2026-09-15T21:46:04.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A new publication citation for the post hoc analysis of abrocitinib in atopic dermatitis was added to the Publications section, and the previous online-ahead-of-print citation was removed, reflecting a newer version of the paper.
    Difference
    0.0%
    Check dated 2026-09-01T18:02:13.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    An addition appears in the study identifiers: '2019 ( U.S. NIH Grant/Contract )', indicating NIH funding for the U.S. portion of the trial.
    Difference
    0.0%
    Check dated 2026-08-25T16:34:02.000Z thumbnail image

Stay in the know with updates to Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.